Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2003
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562377 Composition to stop hairloss
05/13/2003US6562358 Nontoxic vernix compositions and method of producing
05/13/2003US6562355 Comixture of dextran sulfate/escin for treating skin redness/edema and/or sensitive skin
05/13/2003US6562321 Topical; carrier and one of 3,3'-thiodipropionic acid, thiazolidine-2-carboxylic acid, and kaempferol-7-glucoside, or their derivatives
05/13/2003CA2411750A1 Oligopeptides for promoting hair growth
05/13/2003CA2173863C 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037933A2 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037873A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003WO2003037870A1 Substituted 1h-quinolin-2-one compounds
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037845A1 Compositions for treating acne comprising phytandiol amine
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037288A2 Cosmetic composition that mimics sebum and the use thereof
05/08/2003WO2003037278A1 Surfactant-containing cosmetic cleaning emulsions
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003WO2003037249A2 Method for inhibiting the formation of seromas using factor xiii
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003011224A3 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/08/2003WO2003011217A3 Grifola extracts and methods of use thereof
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
05/08/2003WO2002102304A3 Gum resin as a carrier for topical application of pharmacologically active agents
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002076408A8 Use of creatine, creatinine and/or derivatives thereof
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002053089B1 Stable skin conditioning compositions containing retinoid boosters
05/08/2003WO2002024226A9 Photosensitisers
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001082899A9 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders.
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
05/08/2003US20030087825 Method for inhibiting the formation of seromas using factor XIII
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087789 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087255 Peptides which stimulate the immune response and tissue regeneration
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086971 For therapy of allergic and/or inflammatory conditions of the skin and airway passages
05/08/2003US20030086949 Preparing a substrate containing triacylglycerol; placing in contact with a substance potentially active in the field of lipolysis and with lipoprotein lipase, in the presence of a cofactor to release fatty acid of triacylglycerol; analysis
05/08/2003US20030086947 For diagnosis and prevention of ungulate diseases caused by treponeme spirochete bacteria
05/08/2003US20030086917 Use of sphingomyelinase for producing dermatological and/or cosmetic compositions suitable to be topically applied, to increase the levels of skin and mucosal ceramides
05/08/2003US20030086914 Method and device for inducing biological processes by micro-organs
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465306A1 Substituted 1h-quinolin-2-one compounds
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465123A1 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464945A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464191A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
1 ... 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 ... 1065